Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Eye On The Prize: For $8.7 Billion, Valeant Will Acquire Bausch & Lomb

May 28 2013

Related Content

Valeant Adds Eyetech’s <em>Macugen</em> To Ophthalmic Portfolio

Feb 13 2012

Valeant Continues Buying Spree With $2.6B Acquisition Of Medicis

Sep 04 2012

Valeant’s Latest M&A Gambit Hits Snag With Ista’s Rejection Of $314 Million Buyout Offer

Dec 20 2011

Deals Of The Week: Keeping Score – Valeant Wants Actavis, Which Covets Warner Chilcott …

May 20 2013

Related Companies

Allergan plc

Bausch Health Companies Inc.

Bausch Health Companies Inc.

Medicis Pharmaceutical Corporation

ISTA Pharmaceuticals, Inc.

Novartis AG

Johnson & Johnson

Vistakon

Allergan plc

Additional Topics

Business Strategies Deals Emerging Markets OTC Drugs BioPharmaceutical Consumer Medical Device

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window